STATEMENT OF EXECUTIVE COMPENSATION This Statement of Executive Compensation is filed by ImmunoPrecise Antibodies Ltd. pursuant to Section 11.6 of National.
Sectoral Asset Management Inc. acquired a new position in Scholar Rock Holding Co. (NASDAQ:SRRK – Get Rating) in the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm acquired 151,207 shares of the company’s stock, valued at approximately $1,368,000. A number of other hedge funds and other institutional […]
Scholar Rock (NASDAQ:SRRK – Get Rating) announced its earnings results on Tuesday. The company reported ($0.49) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.57) by $0.08, Briefing.com reports. During the same quarter in the prior year, the business earned ($0.21) EPS. Scholar Rock Trading Down 0.2 % SRRK stock traded […]